Back to User profile » Dr Ute Richarz
Papers published by Dr Ute Richarz:
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
Giron‐Hernandez C, Han JH, Alberio R, Singh A, García-Portilla MP, Pompili M, Knight RK, Richarz U, Gopal S, Antunes J
Neuropsychiatric Disease and Treatment 2023, 19:895-906
Published Date: 13 April 2023
The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia
Milz R, Benson C, Knight K, Antunes J, Najarian D, Lopez Rengel PM, Wang S, Richarz U, Gopal S, Kane JM
Neuropsychiatric Disease and Treatment 2023, 19:531-545
Published Date: 7 March 2023
Galantamine versus donepezil in Chinese patients with Alzheimer’s disease: results from a randomized, double-blind study
Zhang Z, Yu L, Gaudig M, Schäuble B, Richarz U
Neuropsychiatric Disease and Treatment 2012, 8:571-577
Published Date: 4 December 2012
Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS® hydromorphone ER) in patients with chronic pain
Vandenbossche J, Richarz U, Richards HM
Journal of Pain Research 2012, 5:523-533
Published Date: 9 November 2012